Skip to main content

Glucose control during acute myocardial infarction

Buy Article:

$51.00 plus tax (Refund Policy)



The need for tight glycaemic control in the immediate aftermath of myocardial infarction is controversial. Trials of glucose–insulin–potassium (GIK) therapy, given without regard to glucose levels, have only confused the issue. Despite considerable clinical interest, only three randomized controlled trials have, as their primary goal, aimed to determine whether better glycaemic control improves the outcomes of myocardial infarction. This review examines the results of these trials and other data to support the case for tight glycaemic control in patients with myocardial infarction.

Keywords: glucose; hyperglycaemia; insulin; myocardial infarction; therapeutics

Document Type: Research Article


Publication date: 2008-05-01

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more